P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO. 2023; 7(2): 143-159 | DOI: 10.14744/ejmo.2023.29445

Comprehensive Analysis of Biologic and Prognostic Implication for ZNF536 in Pan-Cancer

Yuan Fang1, Shu-jing Wang2, Qiang Wu1
1Department of Pathology, The Second Hospital of Anhui Medical University, Hefei, China, 2School of Basic Medical Sciences, Anhui Medical University, Hefei, China,

Objectives: Zinc Finger Protein 536 (ZNF536) is a highly conserved zinc finger protein, acting as DNA-binding transcription suppressor, and negatively regulating neuron differentiation. However, the role of ZNF536 in cancers is still unknown. Methods: In this study, we aim to comprehensively explore the biologic and prognostic implication of ZNF536 in pancancer by multi-layered analysis. The mRNA differential expression and DNA methylation of ZNF536 in pan-cancer and normal controls based on The Cancer Genome Atlas (TCGA) and Genotype Tissue-Expression (GTEx) data were interpreted. Immunohistochemistry was performed on a tissue micro-array to detect the protein expression of ZNF536. The prognostic implication of ZNF536 in pan-cancer was studied by survival analysis. The cBioPortal database was used to display ZNF536 genomic alterations. The co-expression of ZNF536 and immune-related genes in pan-cancer was investigated. Further research was made on the relationship between ZNF536 expression and tumor immune microenvironment. CancerSEA was employed to excavate the ZNF536 expression at single cell level with different cancer function. The biological function of ZNF536 in pan-cancer was exhibited by gene enrichment analysis. Results: The ZNF536 mRNA was highly expressed in 4 out of 33 cancers, but lowly expressed in 22 cancers. Immunohistochemistry on the tissue micro-array confirmed the high expression of ZNF536 protein in pancreatic adenocarcinoma (PAAD) and low expression in stomach adenocarcinoma (STAD). DNA hypermethylation in prostate adenocarcinoma (PRAD) was observed, which might result in its down-regulated expression. High expression of ZNF536 predicted poor prognosis in 5 cancers, but predicted favorable prognosis in 2 cancers. Genomic alterations of ZNF536 showed mutation in 26 cancers and amplification in 20 cancers. The altered group usually had worse prognosis. ZNF536 mRNA expression was correlated with the degree of immune infiltrates in pan-cancer. Single cell sequencing and gene enrichment analysis showed that the ZNF536-correlated genes might regulate a variety of biological processes in pan-cancer, mainly via angiogenesis pathway. Conclusion: Our results indicated that ZNF536 might be a prognostic and immune-related biomarker for specific malignancies through the angiogenesis pathway. Keywords: Immune, pan-cancer, prognosis, tissue micro-array, ZNF536

Cite This Article

Fang Y, Wang S, Wu Q. Comprehensive Analysis of Biologic and Prognostic Implication for ZNF536 in Pan-Cancer. EJMO. 2023; 7(2): 143-159

Corresponding Author: Qiang Wu

Full Text PDF PDF Download